Patient Financial News

Dr. Rahul Baxi is a Mumbai-based diabetologist, and his patients are rushing to him to ask about the new drug that claims to help with weight loss. In a recent tweet, he shared that many come in with the same question: can they start taking the much-hyped medication to shed extra kilos? India’s fascination with the new Rs 16,000-a-month weight-loss injection is in full swing, with people hoping for a quick fix. However, Dr. Baxi emphasizes that the injection isn’t a magic solution for everyone. Without essential lifestyle changes like a balanced diet, regular walking or exercise, and strength training, the results may not be as effective. He stresses that the medication should only be used under a doctor’s supervision and prescribed to the right patients for the best outcomes. Netizens have shared mixed reactions to the buzz around the new weight-loss injection. Some highlighted the effectiveness of traditional methods, with one person mentioning how regular yoga, evening walks, and home-cooked meals helped lower their HbA1c from 6.2 to 5.8, despite the challenges of maintaining a strict diet in a food-loving city like Indore.

Subscribe to enjoy similar stories. New Delhi: The Indian Pharmacopoeia Commission (IPC), a body under the health ministry, has named five lifesaving drugs as having shown serious side effects. The drugs are Metronidazole, an antibiotic; Luliconazole, an antifungal; Dalteparin, used for cancer treatment; diabetics drug Gliclazide and Tramadol, a painkiller.

Once, Saint Tukaram meditated on banks of the Ganga. A man who observed him became envious of his calm and peaceful demeanour. Wanting to disturb Tukaram and provoke him into anger, he spat on his face, expecting a reaction.

Delhi High Court on Wednesday asked Natco Pharma to maintain status quo on the launch of its drug Risdiplam till April 2. Risdiplam is an oral medicine for spinal muscular atrophy in patients two months of age or older. A Division Bench led by Justice Hari Shankar asked Hyderabad based generic drug manufacturer to hold on its hands till it heard the case on April 2. Swiss multinational F. Hoffmann-La Roche AG's had appealed against a single judge order that had refused to stop Natco Pharma from manufacturing Risdiplam in India for the rare disease.

Association of Mutual Funds in India (AMFI). Effective investment advice and handholding can play a significant role in shaping investment behavior, and it is likely that the growing pool of knowledgeable and experienced distributors has contributed to the increasing trend of long-term investing among women, the study highlighted. Also Read | NFO Insight: This EV ETF from ICICI Prudential Mutual Fund is now open for subscription. Will it electrify your portfolio?

Delhi High Court on Monday rejected Swiss multinational F. Hoffmann-La Roche AG’s petition seeking to temporarily restrain Natco Pharma from infringing its product patent for Risdiplam compound used for treating spinal muscular atrophy. The court noted that the Roche’s approved drug Risdiplam, which is marketed under the name ‘Evrysdi,’ is not available at an affordable prices, thus the public interest would be to outweigh the need for grant of injunction (restraint order). Roche had sought interim injunction against Natco Pharma to restrain infringement of its patent titled «compounds for treating spinal muscular atrophy». The multinational company claimed that its suit patent has a term of 20 years from May 11, 2015 and expires on May 11, 2035.

The Pitt Episode 13 continues the intense storyline from Episode 12. The new episode, titled 7:00 PM, will be released on Max on March 27, 2025. The episode will bring more challenges for the hospital staff as they handle the ongoing crisis.

Dental care provider Clove Dental announced the opening of its 600th clinic in Gurugram on its 14th anniversary. Established in 2011, Clove Dental has grown into a network spanning over 26 cities, having served more than 3 million satisfied patients. Similar to all our existing clinics, the new Gurugram clinic is equipped with state-of-the-art technology and adheres to strict safety and hygiene protocols. Louis Shakinovsky, Group Chairman of Global Dental Services, said in a statement, «Credibility is doing what you say. Our Clove team has unquestionably done this convincingly. Since its inception in 2011, Clove Dental has been on a mission to transform dental care in India. A few years ago, I had envisioned an ambitious goal to reach 600 clinics. It makes me feel joyous to see this become a reality.” Amarinder Singh, Founder & CEO of Clove Dental, said, „At Clove Dental, we believe that trust is the foundation of effective healthcare. Our commitment to transparency ensures that patients are fully informed about their treatment options and computer-controlled pricing. We provide clear communication, and detailed treatment plans for all procedures, ensuring complete compliance to the measures laid by the Dental Council of India. At Clove Dental, we implement world-class quality control processes, leveraging AI and computer vision for unmatched sterilization adherence—pioneering a first-of-its-kind standard in global dental care.“

Subscribe to enjoy similar stories. New Delhi: The Central government has authorized the Pharmacy Council of India (PCI) to check the attendance data of officials, faculty and students with pharmacy colleges after coming across multiple cases of people using fake IDs.

left ventricular assist devices (LVADs), which help the heart pump blood, people familiar with the matter told ET. This will help patients with end-stage heart failure as they wait for a donor heart. According to government estimates, every year, some 50,000 patients in India need a heart transplant, but only about 200 such operations are done because of shortage of donor hearts. The average wait time for a heart transplant is about 36 months. Also, an imported LVAD could cost anywhere between ₹70 lakh and ₹1 crore. Surgery and post-treatment care are added expenses.

Subscribe to enjoy similar stories. Communication is key to creating a healthy bond between doctors and patients. Doctors have a message for patients: Trust is a two-way street.

Dr. Stephen Williams, a cardiologist at NYU Langone, is issuing a stern warning: a sedentary lifestyle is just as dangerous as lighting up a cigarette. Many patients, he notes, come into his office boasting about how active they are, only to reveal that their version of “staying active” involves using a standing desk. But here’s the catch—standing still isn’t the same as moving. It still qualifies as a sedentary lifestyle, and the risks associated with it are staggering.

Subscribe to enjoy similar stories. BRYAN JOHNSON wants to live for ever. The American businessman pops a hundred pills a day, never eats after 11am, and obsessively monitors dozens of his body’s “biomarkers".

Subscribe to enjoy similar stories. New Delhi: The National Organ and Tissue Transplant Organisation (NOTTO) is preparing guidelines on processing and storage of human bones and aims to create a database of donors, recipients and hospitals with these facilities, as demand for natural bones for reconstructive procedures rises in the country. Processed human bones, or those that have been sterilized to reduce the risk of infection, are required to perform bone fixation surgery in patients who may be suffering from bone cancer, or had a trauma, or other medical conditions that have destroyed their bones.

Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling with increasing rates of obesity and diabetes. U.S.-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative weight-loss drugs, with investor interest also boosting the drugmakers' valuations.

Subscribe to enjoy similar stories. Narayana Health is ramping up its oncology offerings with a new chain of cancer care centres, taking the treatment to patients and keeping them out of hospitals as the disease burden rises in India.

A hair loss drug that first gained popularity in the 1990s is seeing a resurgence of interest

JP Nadda on Wednesday said the government's expenditure on healthcare has reached 1.84 per cent of GDP and is steadily moving towards the target of 2.5 per cent. In his reply to a discussion on the working of the Ministry of Health and Family Welfare, Nadda said in 2013-14, the allocation of funds for healthcare was around Rs 38,000 crore and at present, it has reached Rs 99,000 crore or assume it to be Rs 1 lakh crore. «In 2013-14, the government health expenditure, which includes state and the Centre, was 1.15 per cent, and when the policy was enunciated, it was 1.35 per cent, and now, it is 1.84 per cent of GDP, and we are going very steadily towards 2.5 per cent,» Nadda said. The National Health Policy 2017 has prescribed increasing government health Expenditure (GHE) as a share of GDP to 2.5 per cent by 2025.

Most of us associate Berkshire Hathaway with Warren Buffett and the late Charlie Munger, but in the early 1970s they were part of a trio that also included Rick Guerin.